Introduction: Industry financial relationships for physicians in the United States are reported publicly in the Sunshine Act Open Payments Database. This study aims to highlight trends and compare plastic surgery with subspecialty data, such as hand and craniofacial surgery. Methods: The Open Payments Database was utilized to retrieve all industry relationship payments made to plastic surgeons in the United States from January 1, 2017 to December 31, 2023. The individual payment dollar values per plastic surgeon were evaluated along with their subspecialty, payment year, type of financial relationship, partnering company, and region. Results: On average, there were 35,333 individual payments made to 4050 plastic surgeons, 1336 payments made to 208 hand surgeons, and 1091 payments made to 214 craniofacial surgeons each year. The top five percent of plastic surgeons received 85.0% of the total payment value, while the top five percent of hand and craniofacial surgeons received 99.8% and 87.8%, respectively. Royalties and licensing were the largest type of payment by dollar value for general plastic (43.0%) and craniofacial surgeons (98.4%), but ownership or investment interest was the most valued type of payment for hand surgeons (48.0%). Conclusion: Within the Open Payments Database, there were a variety of industry payments made to plastic, hand, and craniofacial surgeons over the last 7 years. Current trends suggest that the majority of payment dollar value will continue to go to a specific minority of those in plastic surgery and its subspecialties in the form of royalties, licensing, or ownership and investment interests.
BengtsonBP. Shedding some light on the Sunshine Act. Aesthet Surg J. 2015;35(5):NP129–NP130.
2.
LichterPR. Implications of the Sunshine Act: revelations, loopholes, and impact. Ophthalmology. 2015;122(4):653–655.
3.
BaileyCSFehlingsMGRampersaudYRHallHWaiEKFisherCG. Industry and evidence-based medicine: believable or conflicted? A systematic review of the surgical literature. Can J Surg. 2011;54(5):321–326.
4.
BekelmanJELiYGrossCP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289(4):454–465.
5.
MomeniABeckerABannaschHAntesGBlümleAStarkGB. Association between research sponsorship and study outcome in plastic surgery literature. Ann Plast Surg. 2009;63(6):661–664.
6.
LuceEA. Financial conflicts of interest in plastic surgery: background, potential for bias, disclosure, and transparency. Plast Reconstr Surg. 2015;135(4):1149–1155.
7.
KimSYMillardRWNisbetPCoxCCaineED. Potential research participants’ views regarding researcher and institutional financial conflicts of interest. J Med Ethics. 2004;30(1):73–79.
8.
LicurseABarberEJoffeSGrossC. The impact of disclosing financial ties in research and clinical care: a systematic review. Arch Intern Med. 2010;170(8):675–682.
9.
ChaoAHGangopadhyayN. Industry financial relationships in plastic surgery: analysis of the Sunshine Act open payments database. Plast Reconstr Surg. 2016;138(2):341e–348e. doi:https://doi.org/10.1097/PRS.0000000000002404
KhetpalSMetsEJAhmadM,et al.The open payments Sunshine Act database revisited: a 5-year analysis of industry payments to plastic surgeons. Plast Reconstr Surg.November 2021;148(5):877e–878e. DOI: https://doi.org/10.1097/PRS.0000000000008476
14.
CampbellEGGruenRLMountfordJMillerLGClearyPDBlumenthalD. A national survey of physician-industry relationships. N Engl J Med. 2007;356(17):1742–1750.
15.
LopezJLopezSMeansJ, et al.Financial conflicts of interest: an association between funding and findings in plastic surgery. Plast Reconstr Surg. 2015;136(5):690e–697e.
16.
AmiriARKanesalingamKCroSCaseyAT. Does source of funding and conflict of interest influence the outcome and quality of spinal research?Spine J. 2014;14(2):308–314.
17.
OkikeKKocherMSMehlmanCTBhandariM. Conflict of interest in orthopaedic research: an association between findings and funding in scientific presentations. J Bone Joint Surg Am. 2007;89(3):608–613.
18.
KhetpalSLeNKAhmadM, et al.Trends in industry-sponsored research in plastic surgery since implementation of the Sunshine Act. J Plast Reconstr Aesthet Surg. 2022;75(6):2019–2026. doi:https://doi.org/10.1016/j.bjps.2021.12.002
19.
BowmanMAPearleDL. Changes in drug prescribing patterns related to commercial company funding of continuing medical education. J Contin Educ Health Prof. 1988;8(1):13–20.
20.
ChrenMMLandefeldCS. Physicians’ behavior and their interactions with drug companies: a controlled study of physicians who requested additions to a hospital drug formulary. JAMA.1994;271(9):684–689.
21.
SmithJEWahleCBernatJLRobbinsNM. Financial conflicts of interest of United States-based authors in neurology journals: cross-sectional study using the open payments database. Neurology. 2021;96(14):e1913–e1920. doi:https://doi.org/10.1212/WNL.0000000000011701
22.
LicurseABarberEJoffeSGrossC. The impact of disclosing nancial ties in research and clinical care: a systematic review. Arch Intern Med. 2010;170(8):675–682.
